Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Evaxion A/S - Sponsored ADR (EVAX : NSDQ)

• Company Description    Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark. Number of Employees: 46

• Price / Volume Information    Yesterday's Closing Price: $2.96 Daily Weekly Monthly 20 Day Moving Average: 15,581 shares Shares Outstanding: 8.34 (millions) Market Capitalization: $24.69 (millions) Beta: 0.26 52 Week High: $12.15 52 Week Low: $2.45 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -4.21% -4.96% 12 Week -34.15% -35.76% Year To Date -37.94% -42.69%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Dr. Neergaards Vej 5F - Hoersholm,G7 2970 DNK ph: 45-3131-9753 fax: - mak@evaxion.ai http://www.evaxion.ai

• General Corporate Information    Officers Helen Tayton-Martin - Chief Executive Officer Marianne Sogaard - Chairman of the Board of Directors Thomas Frederik Schmidt - Chief Financial Officer Lars Holtug - Director Roberto Prego - Director Peer Information Evaxion A/S - Sponsored ADR (HLIS) Evaxion A/S - Sponsored ADR (AZTA) Evaxion A/S - Sponsored ADR (APYI) Evaxion A/S - Sponsored ADR (RNVA) Evaxion A/S - Sponsored ADR (HMSY) Evaxion A/S - Sponsored ADR (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 29970R303 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/20/26 Share - Related Items Shares Outstanding: 8.34 Most Recent Split Date: 1.00 (0.20:1) Beta: 0.26 Market Capitalization: $24.69 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.50 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/20/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.87 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -51.72% vs. Previous Quarter: 56.00% Sales Growth vs. Year Ago Period: 148.33% vs. Previous Quarter: 20,148.65% ROE 06/30/26 - - 03/31/26 - -73.56 12/31/25 - -61.43 ROA 06/30/26 - - 03/31/26 - -37.45 12/31/25 - -29.14 Current Ratio 06/30/26 - - 03/31/26 - - 12/31/25 - 5.85 Quick Ratio 06/30/26 - - 03/31/26 - - 12/31/25 - 5.85 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - - 03/31/26 - -141.96 12/31/25 - -114.44 Book Value 06/30/26 - - 03/31/26 - 1.58 12/31/25 - 2.04 Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - - 03/31/26 - - 12/31/25 - 0.41 Debt-to-Capital 06/30/26 - - 03/31/26 - - 12/31/25 - 28.98

Powered by Zacks Investment Research ©